Glucagon receptor signaling — hepatic glycogenolysis and lipolysis

Dr.SleepRoch said:

The liver data is among the strongest non-weight findings in the class.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Dr.SurgeonPGH said:

It helps to say which part of this you are uncertain about.

I read this differently from Dr.SurgeonPGH, on substance rather than tone. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Moderator note: the sourcing question belongs in the vendor section and has been split out.